Home
About
Pricing
Log In
Back
COI
Asset Logo

Comet Ridge Limited

🇦🇺 ASX

⚡️ ENERGY

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 6.37%
Annual Growth

5 years average annual capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

5
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Comet Ridge Ltd. operates as a coal seam gas exploration and development company. The company is headquartered in Brisbane, Queensland. The company went IPO on 2004-04-19. The company has tenement interests and a suite of prospective projects in Queensland. The Company’s flagship gas project comprises the Mahalo Gas Hub assets located in central Queensland, 240 kilometers to the gas demand center of Gladstone. The Mahalo Gas Hub assets comprise the Mahalo Gas Project, which is an appraised coal seam gas project with certified gas reserves and petroleum leases and the Northern Mahalo Projects, which comprising Mahalo North, Mahalo East, and Mahalo Far East. The company holds an acreage position of 4,998 square kilometers (km2) in the eastern part of the Galilee Basin. The Galilee Project has various prospects, including ATP 743, ATP 744, and ATP 1015. Its Mahalo North includes a project area of 450 km2. Its Mahalo East includes a project area of approximately 97 km2. Its Mahalo Far East includes a project area of 338 km2.

📈 Performance

Price History

+25.00%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.12

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in COI

5

📊 Total Capital Earnings

$3K

🔃 Average investment frequency

36 weeks

💵 Average investment amount

$4,038

Last time a customer invested in COI

319 days
COI investor breakdown
💵 Income of investors

More than 200k

17%

150k - 200k

100k - 150k

17%

50k - 100k

33%

Less than 50k

33%
👶 Age of investors

18 - 25

20%

26 - 34

35 - 90

80%
🙋 Legal gender of investors

Female

20%

Male

80%

Pearlers who invest in COI also invest in...

Cobalt Blue Holdings Limited

COB

Cobalt Blue Holdings Ltd. engages in the exploration, development, and marketing of cobalt properties. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2017-02-02. The Company’s operations include Broken Hill Cobalt Project (BHCP), near Broken Hill, New South Wales, the Kwinana Refinery Project (KRP) and Cobalt in Waste Streams Projects. The Broken Hill Cobalt Project is located approximately 25 kilometers (km) southwest of Broken Hill, in far western New South Wales. The Project covers an area of roughly 37 square kilometers (km2) within a tenement holding of almost 220 km2. The Broken Hill Cobalt Project has seven tenement holdings, which include EL 6622, EL 8143, EL 8891, EL 9139, EL 9254, ML 86 and ML 87. The portfolio of tenements is located about 23 km southwest of Broken Hill. The Kwinana Refinery Project is a proposed cobalt/nickel refinery located in Western Australia producing battery ready sulphates as feedstock for electric vehicle batteries. Its processing technology provides sustainable solutions for recycling mine waste.

🙌 Performance (5Yr p.a)

-1.59%

📊 Share price

$0.08 AUD

⛏️ MINING

Find Out More

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 32,065 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

🙌 Performance (5Yr p.a)

-5.63%

📊 Share price

$207.79 AUD

⚖️ HIGH GOVERNANCE

🕊️ SOCIALLY AWARE

🧬 BIOTECHNOLOGY

MVW.AX was created on 2014-03-04 by VanEck. The fund's investment portfolio concentrates primarily on large cap equity. MVW.AX invests in a diversified portfolio of ASX-listed securities with the aim of providing investment returns before fees and other costs that track the performance of the MVIS Australia Equal Weight Index

🙌 Performance (5Yr p.a)

9.17%

📊 Share price

$40.25 AUD

🇦🇺 AUSTRALIA

🧱 MATERIALS

📈 HIGH PRICE GROWTH

⚡️ ENERGY

BrainChip Holdings Ltd. engages in the development of software and hardware solutions for artificial intelligence and machine learning applications. The company is headquartered in Sydney, New South Wales and currently employs 63 full-time employees. The company went IPO on 2011-11-09. The Company’s software and hardware accelerated solutions for advanced AI and machine learning applications with a primary focus on the development of its Akida Neuromorphic Processor. The Company’s fully digital, event-based AI processor, Akida, uses neuromorphic principles to mimic the human brain, analyzing only essential sensor inputs at the point of acquisition, processing data with unparalleled efficiency, precision, and economy of energy. Akida enables Edge learning local to the chip, independent of the cloud, reducing latency while improving privacy and data security. Its other products include MetaTF, 2nd Generation akida, Akida1000 reference chip and Akida Enablement Platforms. Akida Enablement Platforms include Akida PCIe Board, Akida Development Kit Shuttle PC, and Akida Development Kit Raspberry Pi.

🙌 Performance (5Yr p.a)

-7.88%

📊 Share price

$0.20 AUD

🤖 TECHNOLOGY

Weebit Nano Ltd. engages in developing and commercializing silicon oxide and Resistive Random-Access Memory technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-12-21. The Company’s Resistive RAM (ReRAM) addresses the growing need for higher performance and lower power non-volatile memory (NVM) solutions in a range of new electronic products, such as Internet of Things (IoT) devices, smartphones, robotics, autonomous vehicles, fifth generation (5G) communications and artificial intelligence. Its ReRAM technology is based on fab-friendly materials and can be easily integrated with existing flows and processes. The firm is creating ReRAM IP that customers can embed in their system-on-chip (SoC) designs. The company is also developing discrete (stand-alone) memory technology, targeting storage class memory, persistent memory and NOR flash replacement.

🙌 Performance (5Yr p.a)

76.82%

📊 Share price

$3.57 AUD

🤖 TECHNOLOGY

Want more shares? Try these...

Cochlear Ltd. engages in the provision of implantable hearing solutions. The company is headquartered in Sydney, New South Wales and currently employs 5,500 full-time employees. Its segments include Cochlear Implants, Services, and Acoustics. Cochlear Implants segment offers Cochlear implant systems. Services segment offers sound processor upgrades, accessories and other. Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Its Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.

🙌 Performance (5Yr p.a)

8.48%

📊 Share price

$283.46 AUD

🕊️ SOCIALLY AWARE

📈 HIGH PRICE GROWTH

🩺 HEALTH CARE

Compare
Add to watchlist